<?xml version="1.0" encoding="UTF-8"?>
<p>Subsequent experiments focused on H3‐HA‐specific responses as a result of the challenge of antigenic matching for current vaccines and reduced vaccine efficacy.
 <xref rid="cti21107-bib-0003" ref-type="ref">3</xref>, 
 <xref rid="cti21107-bib-0006" ref-type="ref">6</xref> Our initial study also found improved responses to enhanced vaccines for H3N2 viruses,
 <xref rid="cti21107-bib-0018" ref-type="ref">18</xref> and we also observed similar trends for H1‐HA‐specific responses (Supplementary figures 
 <xref rid="cti21107-sup-0001" ref-type="supplementary-material">1</xref> and 
 <xref rid="cti21107-sup-0001" ref-type="supplementary-material">5</xref>) and influenza B responses with limited reagents (data not shown).
</p>
